Skip to main content
Erschienen in: European Radiology 12/2020

03.07.2020 | Interventional

Oligometastatic adrenocortical carcinoma: the role of image-guided thermal ablation

verfasst von: Andrea Veltri, Domenico Basile, Marco Calandri, Chiara Bertaggia, Marco Volante, Francesco Porpiglia, Anna Calabrese, Soraya Puglisi, Vittoria Basile, Massimo Terzolo

Erschienen in: European Radiology | Ausgabe 12/2020

Einloggen, um Zugang zu erhalten

Abstract

Objectives

To evaluate the impact of image-guided ablation of liver and lung metastases from adrenocortical carcinoma (ACC).

Methods

Patients with oligometastatic ACC (liver and lung metastases) who underwent image-guided ablation were retrospectively included in the study. Complete ablation (CA) at the first contrast-enhanced CT control, local tumor progression (LTP), local tumor progression-free survival (LTPFS), liver disease-free survival (LDFS), and overall survival (OS) were evaluated. Correlation between outcomes and other prognostic factors (including Ki67, hormonal secretion, and progression-free survival after primary tumor resection (PR-PFS)) was also analyzed. Kaplan-Meier methods, log-rank tests, and Spearman correlation models were applied.

Results

Thirty-two ACC metastases (4 lung and 28 liver) from 16 patients (10 females; mean age 41 years) were treated with RFA or MWA. A single major adverse event was observed (intrahepatic hematoma with subsequent right hemothorax). One patient (2 lesions) was lost to follow-up. CA was obtained in 97% (29/30). During follow-up, LTP was registered in 7/29 cases (24.1%), with a median LTPFS of 21 months (± 12.6). Metastasis size was significantly higher in case of LTP (20 mm vs. 34.5 mm; p = 0.009) and was an independent predictive factor of local tumor control with an AUC of 0.934 (p = 0.0009). Hepatic progression was observed in 66% of the cases, with a median LDFS of 25 months. Median OS was 48.6 months. PR-PFS and hormonal secretion were independent predictors of OS (p < 0.001 and p = 0.045, respectively).

Conclusions

Image-guided ablation achieves adequate local tumor control of ACC liver and lung metastases, providing a safe and effective treatment option in the multidisciplinary management of the oligometastatic ACC.

Key Points

• Image-guided ablation allows adequate local tumor control in the oligometastatic adrenocortical carcinoma setting.
• After percutaneous thermal ablation, complete ablation was achieved in 29 out of 30 lesions (97%).
• Lesion size together with primary resection disease-free survival and hormonal secretion play a significant role in determining outcomes.
Literatur
1.
Zurück zum Zitat Gaujoux S, Mihai R, the joint working group of ESES and ENSAT (2017) European Society of Endocrine Surgeons (ESES) and European Network for the Study of Adrenal Tumours (ENSAT) recommendations for the surgical management of adrenocortical carcinoma. Br J Surg 104:358–376CrossRef Gaujoux S, Mihai R, the joint working group of ESES and ENSAT (2017) European Society of Endocrine Surgeons (ESES) and European Network for the Study of Adrenal Tumours (ENSAT) recommendations for the surgical management of adrenocortical carcinoma. Br J Surg 104:358–376CrossRef
2.
Zurück zum Zitat Terzolo M, Angeli A, Fassnacht M et al (2007) Adjuvant mitotane treatment for adrenocortical carcinoma. N Engl J Med 356:2372–2380CrossRef Terzolo M, Angeli A, Fassnacht M et al (2007) Adjuvant mitotane treatment for adrenocortical carcinoma. N Engl J Med 356:2372–2380CrossRef
4.
Zurück zum Zitat Terzolo M, Daffara F, Ardito A et al (2014) Management of adrenal cancer: a 2013 update. J Endocrinol Invest 37:207–217CrossRef Terzolo M, Daffara F, Ardito A et al (2014) Management of adrenal cancer: a 2013 update. J Endocrinol Invest 37:207–217CrossRef
5.
Zurück zum Zitat Fassnacht M, Libé R, Kroiss M, Allolio B (2011) Adrenocortical carcinoma: a clinician’s update. Nat Rev Endocrinol 7:323–335CrossRef Fassnacht M, Libé R, Kroiss M, Allolio B (2011) Adrenocortical carcinoma: a clinician’s update. Nat Rev Endocrinol 7:323–335CrossRef
6.
Zurück zum Zitat Schulick RD, Brennan MF (1999) Long-term survival after complete resection and repeat resection in patients with adrenocortical carcinoma. Ann Surg Oncol 6:719–726CrossRef Schulick RD, Brennan MF (1999) Long-term survival after complete resection and repeat resection in patients with adrenocortical carcinoma. Ann Surg Oncol 6:719–726CrossRef
7.
Zurück zum Zitat Wood BJ, Abraham J, Hvizda JL, Alexander HR, Fojo T (2003) Radiofrequency ablation of adrenal tumors and adrenocortical carcinoma metastases. Cancer 97:554–560 Wood BJ, Abraham J, Hvizda JL, Alexander HR, Fojo T (2003) Radiofrequency ablation of adrenal tumors and adrenocortical carcinoma metastases. Cancer 97:554–560
8.
Zurück zum Zitat Ripley RT, Kemp CD, Davis JL et al (2011) Liver resection and ablation for metastatic adrenocortical carcinoma. Ann Surg Oncol 18:1972–1979CrossRef Ripley RT, Kemp CD, Davis JL et al (2011) Liver resection and ablation for metastatic adrenocortical carcinoma. Ann Surg Oncol 18:1972–1979CrossRef
9.
Zurück zum Zitat Datrice NM, Langan RC, Ripley RT et al (2012) Operative management for recurrent and metastatic adrenocortical carcinoma. J Surg Oncol 105:709–713CrossRef Datrice NM, Langan RC, Ripley RT et al (2012) Operative management for recurrent and metastatic adrenocortical carcinoma. J Surg Oncol 105:709–713CrossRef
10.
Zurück zum Zitat Fassnacht M, Dekkers OM, Else T et al (2018) European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors. Eur J Endocrinol 179:G1–G46CrossRef Fassnacht M, Dekkers OM, Else T et al (2018) European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors. Eur J Endocrinol 179:G1–G46CrossRef
11.
Zurück zum Zitat Fassnacht M, Arlt W, Bancos I et al (2016) Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors. Eur J Endocrinol 175:G1–G34CrossRef Fassnacht M, Arlt W, Bancos I et al (2016) Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors. Eur J Endocrinol 175:G1–G34CrossRef
12.
Zurück zum Zitat Beuschlein F, Weigel J, Saeger W et al (2015) Major prognostic role of Ki67 in localized adrenocortical carcinoma after complete resection. J Clin Endocrinol Metab 100:841–849CrossRef Beuschlein F, Weigel J, Saeger W et al (2015) Major prognostic role of Ki67 in localized adrenocortical carcinoma after complete resection. J Clin Endocrinol Metab 100:841–849CrossRef
14.
Zurück zum Zitat Fassnacht M, Terzolo M, Allolio B et al (2012) Combination chemotherapy in advanced adrenocortical carcinoma. N Engl J Med 366:2189–2197CrossRef Fassnacht M, Terzolo M, Allolio B et al (2012) Combination chemotherapy in advanced adrenocortical carcinoma. N Engl J Med 366:2189–2197CrossRef
15.
Zurück zum Zitat Wängberg B, Khorram-Manesh A, Jansson S et al (2010) The long-term survival in adrenocortical carcinoma with active surgical management and use of monitored mitotane. Endocr Relat Cancer 17:265–272CrossRef Wängberg B, Khorram-Manesh A, Jansson S et al (2010) The long-term survival in adrenocortical carcinoma with active surgical management and use of monitored mitotane. Endocr Relat Cancer 17:265–272CrossRef
16.
Zurück zum Zitat Bertot LC, Sato M, Tateishi R, Yoshida H, Koike K (2011) Mortality and complication rates of percutaneous ablative techniques for the treatment of liver tumors: a systematic review. Eur Radiol 21:2584–2596 Bertot LC, Sato M, Tateishi R, Yoshida H, Koike K (2011) Mortality and complication rates of percutaneous ablative techniques for the treatment of liver tumors: a systematic review. Eur Radiol 21:2584–2596
17.
Zurück zum Zitat Pathak S, Jones R, Tang JMF et al (2011) Ablative therapies for colorectal liver metastases: a systematic review: ablation for colorectal liver metastases. Colorectal Dis 13:e252–e265CrossRef Pathak S, Jones R, Tang JMF et al (2011) Ablative therapies for colorectal liver metastases: a systematic review: ablation for colorectal liver metastases. Colorectal Dis 13:e252–e265CrossRef
Metadaten
Titel
Oligometastatic adrenocortical carcinoma: the role of image-guided thermal ablation
verfasst von
Andrea Veltri
Domenico Basile
Marco Calandri
Chiara Bertaggia
Marco Volante
Francesco Porpiglia
Anna Calabrese
Soraya Puglisi
Vittoria Basile
Massimo Terzolo
Publikationsdatum
03.07.2020
Verlag
Springer Berlin Heidelberg
Erschienen in
European Radiology / Ausgabe 12/2020
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-020-07019-w

Weitere Artikel der Ausgabe 12/2020

European Radiology 12/2020 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.